4.3 Letter

T315L: a novel mutation within BCR-ABL kinase domain confers resistance against ponatinib

Journal

LEUKEMIA & LYMPHOMA
Volume 58, Issue 7, Pages 1733-1735

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/10428194.2016.1251591

Keywords

-

Funding

  1. Zhejiang medical and health science and technology project [2012KYB080, 2012KYB067]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available